Breast Endocrine & Surgical Oncology
Associate Professor P Grantley Gill
| Head Of Unit | Breast, Endocrine & Surgical Oncology Unit, Royal Adelaide Hospital. |
| Associate Professor | Department of Surgery, University Of Adelaide. |
| Surgical Coordinator | BreastScreen South Australia. |
COMMITTEES:
- Medical Executive Committee - BreastScreen SA
- Chair - Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
- State Accreditation Committee - BreastScreen SA
TEACHING/ACADEMIC:
- Breast Lump Module - Problem based learning - University of Adelaide
- Postgraduate Courses - Management of Early screen detected breast cancer (March, September 2003)
- Clinical Tutorials for 4 th, 5 th, and 6 th Year Medical Students
CLINICAL RESEARCH PROJECTS
- Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
- ANZ Breast Cancer Trial Group - BIG 1-98 Study
- C-VAX Stage III & IV Study
- BIG-98 trial (Adjuvant Letrozole versus Tamoxifen in ER positive breast cancer)
MEETINGS/COURSES ATTENDED:
- Royal Australasian College of Surgeons Annual Scientific Meeting – Melb May 2005
- Leura International Breast Conference –Invited Speaker - Sydney, November 2004
- International Association of Pathologists – Invited Speaker - Brisbane, October 2004
- International Sentinel Node Society – Invited Speaker - Los Angeles, December 2004
- SNAC Investigators Meeting - Melbourne, May 2004
- Royal Australasian College of Surgeons, State Branch, Annual Scientific Meeting September 2004
GRANTS:
- NH&MRC – The SNAC Trial (continuing grant) $1.2 million over 5 years – Gill et all
- National Breast Cancer Foundation $94,000 pa for 2004 and 2005 the SNAC Trial - Gill et al
- Anti Cancer Council of South Australia $24,000 for 2004 – Gill P G., Kollias J., Bochner M.
CLINICAL RESEARCH PROJECTS:
- Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
- ANZ Breast Cancer Trial Group-BIG 1-98 Study
- C-VAX Stage III & IV Study
- BIG-98 trial (Adjuvant Letrozole versus Tamoxifen in ER positive breast cancer)
PUBLICATIONS:
- Detection by screening mammography is a powerful independent predictor of survival
- in women diagnosed with breast cancer –P G Gill, G Farshid, C G Luke, D M Roder
- Implication of intraoperative sentinel node imprint cytology for consent in the SNAC
- Trial. ANZ J Surg, 74: 105-197 Bochner MA, Kollias J, Gill PG, Farshid G, Dodd TJ.
- (2004)
- Breast volume replacement using the latissimus dorsi miniflap. ANZ J Surg, 74: 98-
- 104. Nano MT, Gill PG, Kollias J, Bochner M. (2004)
- Sentinel Lymph Node dissection and lymphatic mapping for local subcutaneous
- recurrence in melanoma treatment: longer-term follow-up results. Annals of Surgery.
- Ann Surg Oncol, Mar-Apr; 11(3 Suppl): 203S-7S. Coventry BJ, Gill PG, Chatterton B.
- (2004)
- Sentinel Lymph Node biopsy versus axillary clearance in operable breast cancer:
- The RACS SNAC Trial, A multicentre randomized trial of the Royal Australasian College
- Surgeons (RACS Section of Breast Surgery, in collaboration with the National Health
- & Medical Research Council Clinical Trails Center. Annals Surg Oncol, Mar-Apr;11(3 Supp): 216S-21S. Gill PG (2004)

